Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.45
+0.84003.16%
Pre-market: 27.470.0200+0.07%04:13 EDT
Volume:60.10M
Turnover:1.65B
Market Cap:156.07B
PE:20.18
High:27.76
Open:26.82
Low:26.82
Close:26.61
52wk High:27.94
52wk Low:20.92
Shares:5.69B
Float Shares:5.68B
Volume Ratio:1.63
T/O Rate:1.06%
Dividend:1.72
Dividend Rate:6.27%
EPS(TTM):1.36
EPS(LYR):1.36
ROE:8.89%
ROA:5.68%
PB:1.80
PE(LYR):20.12

Loading ...

Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga_recent_news
·
Feb 02

How Pfizer’s Novavax Matrix-M Deal and GIST Breakthrough (PFE) Has Changed Its Investment Story

Simply Wall St.
·
Jan 31

Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 31

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Jan 30

Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Pfizer (PFE) and Alpha Teknova (TKNO)

TIPRANKS
·
Jan 29

Wolfe Research Adjusts Price Target on Pfizer to $25 From $24, Maintains Underperform Rating

MT Newswires Live
·
Jan 28

CMS Names Pfizer, Eli Lilly, and AbbVie Drugs for Third Medicare Price Talks

TIPRANKS
·
Jan 28

Pfizer Reshapes Pipeline With Novavax Deal And ViiV Exit

Simply Wall St.
·
Jan 28

US names HIV, arthritis drugs for next Medicare price talks

Reuters
·
Jan 28

Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 28

Why Is Pfizer Stock Rising Tuesday?

Benzinga
·
Jan 28

Pfizer Is Maintained at Neutral by Cantor Fitzgerald

Dow Jones
·
Jan 28

Moderately bullish activity in Pfizer with shares up 2.14%

TIPRANKS
·
Jan 27

Citi Keeps Their Hold Rating on Pfizer (PFE)

TIPRANKS
·
Jan 27

Cantor Fitzgerald Adjusts Price Target on Pfizer to $27 From $24, Maintains Neutral Rating

MT Newswires Live
·
Jan 27

Earning Preview: Pfizer’s revenue is expected to decrease by 2.32%, and institutional views are cautious

Earnings Agent
·
Jan 27

Pfizer and BioNTech Move Closer to a Single-Shot Flu–COVID Vaccine: What Investors Should Watch

TIPRANKS
·
Jan 27

Pfizer CEO Calls RFK's Vaccine Views Anti-Science, Warns US Falling Behind China In Health Research

Benzinga_recent_news
·
Jan 24